首页> Cancer research> Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.

Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Steve,Paltoglou

第一单位： Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, South Australia, Australia.;Freemasons Foundation Centre for Men's Health, Adelaide Medical School, The University of Adelaide, South Australia, Australia.

作者： Steve,Paltoglou ^[1] ; Rajdeep,Das ^[1] ; Scott L,Townley ^[1] ; Theresa E,Hickey ^[1] ; Gerard A,Tarulli ^[1] ; Isabel,Coutinho ^[1] ; Rayzel,Fernandes ^[1] ; Adrienne R,Hanson ^[1] ; Iza,Denis ^[1] ; Jason S,Carroll ^[2] ; Scott M,Dehm ^[3] ; Ganesh V,Raj ^[4] ; Stephen R,Plymate ^[5] ; Wayne D,Tilley ^[1] ; Luke A,Selth ^[6]

作者单位： Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, South Australia, Australia.;Freemasons Foundation Centre for Men's Health, Adelaide Medical School, The University of Adelaide, South Australia, Australia. ^[1] Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. ^[2] Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.;Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. ^[3] Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas. ^[4] Department of Medicine and VAPSHCS, University of Washington, Seattle, Washington. ^[5] Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, South Australia, Australia. luke.selth@adelaide.edu.au.;Freemasons Foundation Centre for Men's Health, Adelaide Medical School, The University of Adelaide, South Australia, Australia. ^[6]